By week twelve, clinical trials show participants typically achieve at least five percent body weight reduction from baseline
Potential risks include pancreatitis, gallbladder problems, severe gastrointestinal symptoms, dehydration-related kidney issues, low blood sugar when combined with certain diabetes medications, allergic reactions, and boxed warnings related to thyroid C-cell tumors based on animal data
The starting dose of semaglutide is 0.25 mg subcutaneous once weekly, which can be increased incrementally every four weeks to a maintenance dose of 2.4 mg: 250 weeks 14: 0.25 mg weeks 58: 0.5 mg weeks 912: 1 mg weeks 1316: 1.7 mg maintenance dose: 2.4 mg
Follow with your preferred Murad treatment or moisturizer and SPF during the day
SubQ daily enables smaller, more frequent amounts with the ability to increase after the first week, depending on clinical direction